These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 16150917

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Peptide-YY3-36/glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries.
    Boland BB, Laker RC, O'Brien S, Sitaula S, Sermadiras I, Nielsen JC, Barkholt P, Roostalu U, Hecksher-Sørensen J, Sejthen SR, Thorbek DD, Suckow A, Burmeister N, Oldham S, Will S, Howard VG, Gill BM, Newton P, Naylor J, Hornigold DC, Austin J, Lantier L, McGuinness OP, Trevaskis JL, Grimsby JS, Rhodes CJ.
    Mol Metab; 2022 Jan; 55():101392. PubMed ID: 34781035
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45. Effect of peptide YY3-36 on food intake in humans.
    Degen L, Oesch S, Casanova M, Graf S, Ketterer S, Drewe J, Beglinger C.
    Gastroenterology; 2005 Nov; 129(5):1430-6. PubMed ID: 16285944
    [Abstract] [Full Text] [Related]

  • 46. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
    Rüttimann EB, Arnold M, Hillebrand JJ, Geary N, Langhans W.
    Endocrinology; 2009 Mar; 150(3):1174-81. PubMed ID: 18948395
    [Abstract] [Full Text] [Related]

  • 47. Effects of oligofructose on appetite profile, glucagon-like peptide 1 and peptide YY3-36 concentrations and energy intake.
    Verhoef SP, Meyer D, Westerterp KR.
    Br J Nutr; 2011 Dec; 106(11):1757-62. PubMed ID: 21679485
    [Abstract] [Full Text] [Related]

  • 48. Glucagon-like peptide-1: a potent regulator of food intake in humans.
    Gutzwiller JP, Göke B, Drewe J, Hildebrand P, Ketterer S, Handschin D, Winterhalder R, Conen D, Beglinger C.
    Gut; 1999 Jan; 44(1):81-6. PubMed ID: 9862830
    [Abstract] [Full Text] [Related]

  • 49. Gut hormones as peripheral anti obesity targets.
    Small CJ, Bloom SR.
    Curr Drug Targets CNS Neurol Disord; 2004 Oct; 3(5):379-88. PubMed ID: 15544446
    [Abstract] [Full Text] [Related]

  • 50. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway.
    Abbott CR, Monteiro M, Small CJ, Sajedi A, Smith KL, Parkinson JR, Ghatei MA, Bloom SR.
    Brain Res; 2005 May 17; 1044(1):127-31. PubMed ID: 15862798
    [Abstract] [Full Text] [Related]

  • 51. Neurotensin Is Coexpressed, Coreleased, and Acts Together With GLP-1 and PYY in Enteroendocrine Control of Metabolism.
    Grunddal KV, Ratner CF, Svendsen B, Sommer F, Engelstoft MS, Madsen AN, Pedersen J, Nøhr MK, Egerod KL, Nawrocki AR, Kowalski T, Howard AD, Poulsen SS, Offermanns S, Bäckhed F, Holst JJ, Holst B, Schwartz TW.
    Endocrinology; 2016 Jan 17; 157(1):176-94. PubMed ID: 26469136
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Selective FFA2 Agonism Appears to Act via Intestinal PYY to Reduce Transit and Food Intake but Does Not Improve Glucose Tolerance in Mouse Models.
    Forbes S, Stafford S, Coope G, Heffron H, Real K, Newman R, Davenport R, Barnes M, Grosse J, Cox H.
    Diabetes; 2015 Nov 17; 64(11):3763-71. PubMed ID: 26239054
    [Abstract] [Full Text] [Related]

  • 56. Systemic administration of the long-acting GLP-1 derivative NN2211 induces lasting and reversible weight loss in both normal and obese rats.
    Larsen PJ, Fledelius C, Knudsen LB, Tang-Christensen M.
    Diabetes; 2001 Nov 17; 50(11):2530-9. PubMed ID: 11679431
    [Abstract] [Full Text] [Related]

  • 57. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
    Schick RR, Zimmermann JP, vorm Walde T, Schusdziarra V.
    Am J Physiol Regul Integr Comp Physiol; 2003 Jun 17; 284(6):R1427-35. PubMed ID: 12776726
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
    Moriya R, Mashiko S, Ishihara A, Takahashi T, Murai T, Ito J, Mitobe Y, Oda Z, Iwaasa H, Takehiro F, Kanatani A.
    Peptides; 2009 Jul 17; 30(7):1318-22. PubMed ID: 19394383
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.